Mei-Hui Wang

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

China Medical University(Current)

Taipei Medical University

Institute of Nuclear Energy Research

Taipei Medical University Hospital

Mei-Hui Wang is an author at China Medical University specializing in pharmacology, hepatocellular carcinoma pharmacotherapy, and stability of pharmaceutical formulations.

Publications per year

2018–2019

Publications

Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice

Mao-Chi Weng, Mei-Hui Wang, Jai-Jen Tsai et al. · Bioscience Reports · 2018 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration

Chung‐Ming Chen, Chien‐Hsiang Chang, Chih‐Hua Chao et al. · Drug Delivery · 2019 · 28 citations · Full text

Pharmacy, Pharmacology, Bioavailability +13

1–2 of 2